BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8982708)

  • 1. [3H]RX821002 (2-methoxyidazoxan) binds to alpha 2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney.
    Callado LF; Gabilondo AM; Meana JJ
    Eur J Pharmacol; 1996 Dec; 316(2-3):359-68. PubMed ID: 8982708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-affinity conditions for agonists increase the binding of the antagonist [3H]RX821002 to the alpha(2B/C)-adrenoceptor subtypes in human brain and rat kidney.
    Callado LF; Meana JJ
    Eur J Pharmacol; 1997 Jul; 332(1):109-12. PubMed ID: 9298931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment.
    Callado LF; Gabilondo AM; Meana JJ
    Life Sci; 1999; 64(25):2327-39. PubMed ID: 10374896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR; King PR; Louis WJ; Gundlach AL
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
    Wallace DR; Muskardin DT; Zahniser NR
    Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.
    Uhlén S; Muceniece R; Rangel N; Tiger G; Wikberg JE
    Pharmacol Toxicol; 1995 Jun; 76(6):353-64. PubMed ID: 7479575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain.
    Díez-Alarcia R; Pilar-Cuéllar F; Paniagua MA; Meana JJ; Fernández-López A
    Neuroscience; 2006 Aug; 141(1):357-69. PubMed ID: 16697114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
    Mallard NJ; Hudson AL; Nutt DJ
    Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
    Renouard A; Widdowson PS; Millan MJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding.
    Uhlén S; Wikberg JE
    Pharmacol Toxicol; 1991 Nov; 69(5):341-50. PubMed ID: 1687079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
    Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.
    Uhlén S; Wikberg JE
    Br J Pharmacol; 1991 Nov; 104(3):657-64. PubMed ID: 1665747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2A-adrenoceptors mediate activation of non-selective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium.
    Musgrave IF; Seifert R
    Biochem Pharmacol; 1995 Jan; 49(2):187-96. PubMed ID: 7530955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
    Karkanias GB; Etgen AM
    Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.
    Chan SL; Brown CA; Scarpello KE; Morgan NG
    Br J Pharmacol; 1994 Aug; 112(4):1065-70. PubMed ID: 7952865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.